Advanced Search

Home > Journals > International Angiology > Past Issues > International Angiology 2013 February;32(1) > International Angiology 2013 February;32(1):9-36



A Journal on Angiology

Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899

Frequency: Bi-Monthly

ISSN 0392-9590

Online ISSN 1827-1839


International Angiology 2013 February;32(1):9-36


Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management

Lee B. B. 1, Baumgartner I. 2, Berlien H. P. 3, Bianchini G. 4, Burrows P. 5, Do Y. S. 6, Ivancev K. 7, Kool L. S. 8, Laredo J. 9, Loose D. A. 10, Lopez-Gutierrez J. C. 11, Mattassi R. 12, Parsi K. 13, Rimon U. 14, Rosenblatt M. 15, Shortell C. 16, Simkin R. 17, Stillo F. 18, Villavicencio L. 19, Yakes W. 20

1 Division of Vascular Surgery, Department of Surgery, Center for Vascular Malformation and Lymphedema, George Washington University School of Medicine, Washingto DC, USA;
2 Department of Internal Medicine, Director Clinical and Interventional Angiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland;
3 Department of Laser Medicine, Evangelische Elisabeth Klinik, Berlin, Germany;
4 Division of Vascular Surgery, Vascular Surgeon, Center for Vascular Anomalies, I.D.I. Hospital, Rome, Italy;
5 Department of Radiology, Medical College of Wisconsin, Vascular Interventional Radiology, Children’s Hospital of Wisconsin, Milwaukee, WI, USA;
6 Department of Radiology, Samsung Medical Center & Sungkyunkwan University School of Medicine, Seoul, Korea;
7 Department of Interventional Radiology, Complex EVAR Programme, The Royal Free Hospital, London, UK;
8 Department of Interventional Radiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands;
9 Division of Vascular Surgery, Department of Surgery, Center for Vein, Lymphatics, and Vascular Malformation, George Washington University School of medicine, Washington DC, USA;
10 Department for Vascular Surgery, European Centre for the Diagnosis and Treatment of Vascular Malformations, Die Facharztklinik Hamburg, Hamburg, Germany;
11 Director of the Vascular Anomalies Center, Department of Surgery, La Paz Children Hospital, Madrid, Spain;
12 Department of Vascular Surgery, Center for Vascular Malformations “Stefan Belov”, Clinical Institute Humanitas “Mater Domini”, Castellanza, Varese, Italy;
13 Department of Dermatology, St. Vincent’s Hospital, University of New South Wales, Sydney, Australia;
14 Department of Interventional Radiology, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;
15 Connecticut Image Guided Surgery, Fairfield, CT, USA;
16 Division of Vascular Surgery, Program Director, Vascular Residency, Vice Chair of Faculty Affairs, Department of Surgery Duke University Medical Center, Durham, NC, USA;
17 Department of Surgery, Faculty of Medicine, Buenos Aires University, Buenos Aires, Argentina;
18 Department of Vascular Surgery, Center for Vascular Anomalies, I.D.I. Hospital, Rome, Italy;
19 Department of Surgery, Uniformed Services University School of Medicine, Walter Reed Army Medical Center, Bethesda, MD, USA;
20 University of Colorado Health Sciences Center, Vascular Malformation Center Englewood, CO, USA

Arterio-venous malformations (AVMs) are congenital vascular malformations (CVMs) that result from birth defects involving the vessels of both arterial and venous origins, resulting in direct communications between the different size vessels or a meshwork of primitive reticular networks of dysplastic minute vessels which have failed to mature to become ‘capillary’ vessels termed “nidus”. These lesions are defined by shunting of high velocity, low resistance flow from the arterial vasculature into the venous system in a variety of fistulous conditions. A systematic classification system developed by various groups of experts (Hamburg classification, ISSVA classification, Schobinger classification, angiographic classification of AVMs,) has resulted in a better understanding of the biology and natural history of these lesions and improved management of CVMs and AVMs. The Hamburg classification, based on the embryological differentiation between extratruncular and truncular type of lesions, allows the determination of the potential of progression and recurrence of these lesions. The majority of all AVMs are extra-truncular lesions with persistent proliferative potential, whereas truncular AVM lesions are exceedingly rare. Regardless of the type, AV shunting may ultimately result in significant anatomical, pathophysiological and hemodynamic consequences. Therefore, despite their relative rarity (10-20% of all CVMs), AVMs remain the most challenging and potentially limb or life-threatening form of vascular anomalies. The initial diagnosis and assessment may be facilitated by non- to minimally invasive investigations such as duplex ultrasound, magnetic resonance imaging (MRI), MR angiography (MRA), computerized tomography (CT) and CT angiography (CTA). Arteriography remains the diagnostic gold standard, and is required for planning subsequent treatment. A multidisciplinary team approach should be utilized to integrate surgical and non-surgical interventions for optimum care. Currently available treatments are associated with significant risk of complications and morbidity. However, an early aggressive approach to elimiate the nidus (if present) may be undertaken if the benefits exceed the risks. Trans-arterial coil embolization or ligation of feeding arteries where the nidus is left intact, are incorrect approaches and may result in proliferation of the lesion. Furthermore, such procedures would prevent future endovascular access to the lesions via the arterial route. Surgically inaccessible, infiltrating, extra-truncular AVMs can be treated with endovascular therapy as an independent modality. Among various embolo-sclerotherapy agents, ethanol sclerotherapy produces the best long term outcomes with minimum recurrence. However, this procedure requires extensive training and sufficient experience to minimize complications and associated morbidity. For the surgically accessible lesions, surgical resection may be the treatment of choice with a chance of optimal control. Preoperative sclerotherapy or embolization may supplement the subsequent surgical excision by reducing the morbidity (e.g. operative bleeding) and defining the lesion borders. Such a combined approach may provide an excellent potential for a curative result.
Conclusion. AVMs are high flow congenital vascular malformations that may occur in any part of the body. The clinical presentation depends on the extent and size of the lesion and can range from an asymptomatic birthmark to congestive heart failure. Detailed investigations including duplex ultrasound, MRI/MRA and CT/CTA are required to develop an appropriate treatment plan. Appropriate management is best achieved via a multi-disciplinary approach and interventions should be undertaken by appropriately trained physicians.

language: English


top of page